LRRK2 and Parkinson disease: We recently reported that PP1 could mediate the dephosphorylation of LRRK2 and that this could be blocked by treatment with calyculin A, restoring LRRK2 phosphorylation at Ser910/935/955/973 after kinase inhibition and in PD mutants [50].